These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7172676)

  • 21. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L; Tamme E
    J Int Med Res; 1975; 3(2):63-72. PubMed ID: 1140508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of norethisterone, estradiol and progesterone after administration of norethisterone oenanthate at different sites: a cross-over study.
    Virutamasen P; Dhanapas S; Leepipatpaiboon S
    Asia Oceania J Obstet Gynaecol; 1987 Mar; 13(1):49-53. PubMed ID: 3593083
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
    Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
    Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations.
    Brenner PF; Goebelsmann U; Stanczyk FZ; Mishell DR
    Contraception; 1980 Jul; 22(1):85-95. PubMed ID: 7418409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of different doses of norethisterone oenanthate.
    Fotherby K; Hamawi A; Howard G; Bye PG; Elder M
    Contraception; 1984 Apr; 29(4):325-33. PubMed ID: 6744856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
    Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
    Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of norethisterone oenanthate in humans.
    Sang GW; Fotherby K; Howard G; Elder M; Bye PG
    Contraception; 1981 Jul; 24(1):15-27. PubMed ID: 7273765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
    Andino N
    Contraception; 1981 Feb; 23(2):141-55. PubMed ID: 6786825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of injectable biodegradable contraceptive system.
    Beck LR; Ramos RA; Flowers CE; Lopez GZ; Lewis DH; Cowsar DR
    Am J Obstet Gynecol; 1981 Aug; 140(7):799-806. PubMed ID: 7020421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Nayak RK
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postovulatory contraception in women with large doses of norethindrone.
    Nygren KG; Johansson ED; Wide L
    Contraception; 1972 Jun; 5(6):445-56. PubMed ID: 4650660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
    Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
    Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
    Meng YX; Virutamasen P
    Contraception; 1991 Jul; 44(1):73-82. PubMed ID: 1893702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.
    Back DJ; Breckenridge AM; Crawford FE; MacIver M; Orme ML; Rowe PH; Watts MJ
    Contraception; 1979 Sep; 20(3):263-73. PubMed ID: 509953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 microgram norethisterone (NET) minipill.
    Johannisson E; Landgren BM; Diczfalusy E
    Contraception; 1982 Jan; 25(1):13-30. PubMed ID: 7060371
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate.
    Singh H; Uniyal JP; Jha P; Takker D; Murguesan K; Hingorani V; Laumas KR
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):302-8. PubMed ID: 7058686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.